![Shakil Aslam](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 78 838 $ al 30/06/2026
Dr. Shakil Aslam, MD, is a Chief Medical Officer at Talphera, Inc. Dr. Aslam was previously employed as a Vice President-Clinical Development by BioCryst Pharmaceuticals, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
TALPHERA, INC. 0,15 % | 20/05/2026 | 76.542 ( 0,15 % ) | 78 838 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TALPHERA, INC. | Director Técnico/Científico/I+D | 01/10/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
BioCryst Pharmaceuticals, Inc.
 BioCryst Pharmaceuticals, Inc. BiotechnologyHealth Technology Designs and develops oral small-molecule & injectable protein therapeutics | Health Technology |
Talphera, Inc.
 Talphera, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
